72.11.Z - Research and experimental development on biotechnology
20.59.Z - Manufacture of other chemical products not elsewhere classified
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade, except of motor vehicles and motorcycles
47 - Retail trade, except motor vehicle retail
63 - Information service activities
71 - Architectural and engineering activities; technical testing and analysis
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
74 - Other professional, scientific and technical activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 17,4 | 13,1 | 8,9 | -31,8 |
Profit (loss) on sale | -4,1 | -4,1 | -4,1 | -0 |
Gross profit (loss) | -4,1 | -4,3 | -4,2 | 2,8 |
Net profit (loss) | -4,1 | -4,3 | -4,2 | 2,8 |
Cash | 16,7 | 11,5 | 6,6 | -43,1 |
Liabilities and provisions for liabilities | 0,6 | 0,6 | 0,6 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Short time liabilities | 0,6 | 0,6 | 0,6 | 0 |
Other operating costs | 0 | 0,2 | 0,1 | -66,6 |
Working assets | 17,4 | 13,1 | 8,9 | -31,8 |
Equity capital | 16,8 | 12,5 | 8,3 | -33,3 |
Other income costs | 0 | 0 | 0 | 0 |
Operating profit (EBIT) | -4,1 | -4,3 | -4,2 | 2,8 |
% | % | % | p.p. | |
Profitability of capital | -24,4 | -34,3 | -49,9 | -15,6 |
Equity capital to total assets | 96,6 | 95,5 | 93,3 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 29.179019927978516 | 21.986047744750977 | 14.996133804321289 | -7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane